openPR Logo
Press release

Cancer Biologics Therapies Market : Forecast Report Till 2031

05-06-2021 01:36 PM CET | Health & Medicine

Press release from: Visiongain Limited

Cancer Biologics Therapies Market : Forecast Report Till 2031

Visiongain has launched a new report Cancer Biologics Therapies Market Report 2021-2031: Forecasts by Treatment (Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy, Others), by Product (Monoclonal Antibodies, Cytokines, Cancer Growth Blockers, Vaccines, Blood Cell Growth Factors, and Others), by Indication (Breast Cancer, Cervical Cancer, Colon and Rectal Cancer, Gastric Cancer, Lung Cancer, Ovarian Cancer, Renal Cell Cancer, Melanoma), by Biologic Drugs (Bevacizumab, Trastuzumab, Trastuzumab Emtansine, Pertuzumab, Rituximab, Cetuximab, Panitumumab, Ramucirumab, Necitumumab, Pembrolizumab, Atezolizumab, Durvalumab, Nivolumab, Ipilimumab), by End-user (Hospitals, Specialty Clinics, Cancer and Radiation Therapy Centres) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Cancer Biologics Companies AND COVID-19 Recovery Scenarios.

The global demand for cancer biologics therapy is expected to expand significantly over the projected period, owing to the expanded acceptance of biologics by cancer care regulatory authorities.

Click here to Get Complete Synopsis of the Report @ https://www.visiongain.com/report/cancer-biologics-therapies-market-2021/

Cancer Biologics Therapy Market: Regional Landscape
Presence of well-established healthcare infrastructure and biopharmaceutical companies are expected to further strengthen North America cancer biologics therapy market in coming years. Increasing government initiatives to strengthen healthcare industry, rising prevalence of chronic diseases, followed by increasing healthcare expenditure in emerging economies are expected to drive Asia Pacific cancer biologics therapy market over the forecast period.

This report includes data analysis and invaluable insight into how COVID-19 will affect your industry. Access this report today.

What are the Market Driving Factors?
• Rising Cancer Prevalence Worldwide
• Increasing Ageing Population in Developed as well as Developing Economies

Key Challenges for Cancer Biologics Therapy Market
• Shortage of Skilled Workforce in the Biopharmaceutical Industry
• High Cost Associated with Biopharmaceutical Drug Manufacturing

What are the Market Opportunities?
• Increasing R&D Spending of Biopharmaceutical Companies
• Future Perspective in Oncology Industry

Download a Sample Report with Table of Contents and Figures by clicking here @ https://www.visiongain.com/report/cancer-biologics-therapies-market-2021/

Why you Should buy this Report?
Apart from market estimation and forecast to 2031 the report covers below mentioned important factors to offer in-depth analysis of cancer biologics industry
• SWOT Analysis
• Porter’s Five Forces Model
• Oncology Market Trends
• Global Oncology Spending, 2016 – 2031
• Disease Prevalence and Incidence in Europe by Country
• EMA Approved Biologics in Oncology
• Biosimilars and R&D Biologics in Development

Request Customized Report as Per Your Requirements @ https://www.visiongain.com/contact/

What are the Leading Companies Operating in the Market?
• AbbVie Inc
• F.Hoffman La Roche
• GlaxoSmithKline
• Eli Lilly and Company
• Amgen
• Johnson & Johnson
• Merck & Co.
• Pfizer
• Agilent Technologies, Inc.
• Bio-Rad Laboratories
• GE Healthcare
• Illumina
• Qiagen N.V.
• Biocept
• Guardant Health

CTA

Market Segmentation and Scope

Cancer Biologics Therapy Market by Treatment
• Chemotherapy
• Targeted Therapy
• Immunotherapy
• Hormonal Therapy
• Others

Cancer Biologics Therapy Market by Indication
• Breast cancer
• Cervical cancer
• Colon and rectal cancer
• Gastric cancer
• Lung cancer
• Ovarian cancer
• Renal cell cancer
• Melanoma

Cancer Biologics Therapy Market by Biologic Drug
• Bevacizumab
• Trastuzumab
• Trastuzumab emtansine
• Pertuzumab
• Rituximab
• Cetuximab
• Panitumumab
• Ramucirumab
• Necitumumab
• Pembrolizumab
• Atezolizumab
• Durvalumab
• Nivolumab
• Ipilimumab

Cancer Biologics Therapy Market by End User
• Hospitals
• Specialty Clinics
• Cancer and Radiation Therapy Centers

Cancer Biologics Therapy Market by Product
• Monoclonal Antibodies
• Cytokines
• Cancer Growth Blockers
• Vaccines
• Blood Cell Growth Factors
• Others

Cancer Biologics Therapy Market by Region

• North America Cancer Biologics Therapy Market
• U.S. Cancer Biologics Therapy Market
• Canada Cancer Biologics Therapy Market

• Europe Cancer Biologics Therapy Market
• UK Cancer Biologics Therapy Market
• Germany Cancer Biologics Therapy Market
• France Cancer Biologics Therapy Market
• Italy Cancer Biologics Therapy Market
• Spain Cancer Biologics Therapy Market
• Portugal Cancer Biologics Therapy Market
• Poland Cancer Biologics Therapy Market
• Hungary Cancer Biologics Therapy Market
• Czech Republic Cancer Biologics Therapy Market
• Slovakia Cancer Biologics Therapy Market
• Slovenia Cancer Biologics Therapy Market
• Romania Cancer Biologics Therapy Market
• Bulgaria Cancer Biologics Therapy Market
• Croatia Cancer Biologics Therapy Market
• Baltic States Cancer Biologics Therapy Market
• Serbia Cancer Biologics Therapy Market

• Asia Pacific Cancer Biologics Therapy Market
• China Cancer Biologics Therapy Market
• Japan Cancer Biologics Therapy Market
• India Cancer Biologics Therapy Market
• Australia Cancer Biologics Therapy Market
• South Korea Cancer Biologics Therapy Market
• Rest of Asia Pacific Cancer Biologics Therapy Market

• Latin America Cancer Biologics Therapy Market
• Brazil Cancer Biologics Therapy Market
• Mexico Cancer Biologics Therapy Market
• Argentina Cancer Biologics Therapy Market
• Rest of Latin America Cancer Biologics Therapy Market

• Middle East & Africa Cancer Biologics Therapy Market
• South Africa Cancer Biologics Therapy Market
• GCC Cancer Biologics Therapy Market
• Rest of Middle East & Africa Cancer Biologics Therapy Market

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 20 7549 9987.

Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help:

Contact:
Address: Airport House, Purley Way, Surrey, London, CR0 0XZ United Kingdom
Name : Sara Peerun
Email: sara.peerun@visiongain.com
Phone: +44(0)2075499987
Research Insight: https://www.visiongain.com/report/cancer-biologics-therapies-market-2021/

About Visiongain
Visiongain is one of the fastest-growing and most innovative independent market research company in London, the company comprises over 400+ analysts and consultants, adding more than 1400 market research reports to its vast database each year. These reports offer in-depth analysis on 18 industries worldwide.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cancer Biologics Therapies Market : Forecast Report Till 2031 here

News-ID: 2280976 • Views:

More Releases from Visiongain Limited

Animal Autoimmune Disease Diagnostics Market Report Up to 2031
Animal Autoimmune Disease Diagnostics Market Report Up to 2031
Visiongain has published a new report on Animal Autoimmune Disease Diagnostics Market Report to 2031: Forecasts By Test Type (Complete Blood Count, Thyroid Test, Biopsy Test, Urinalysis, DNA Amplification Test, and Immunoassays Test), By Indication (Hypothyroidism, Pemphigus Disease, Canine Lupus, Auto-Immune Hemolytic Anemia, Bullous Pemphigoid, Discoid Lupus Erythematosus (DLE), Autoimmune hemolytic anemia, Immune-related arthritis, and Others), By Animal Type (Companion Animal, Dogs, Cats, Horse, Live Stock Animal, Cattle, Swine, Poultry,
Basil Extract Market Report Up to 2031
Basil Extract Market Report Up to 2031
Visiongain has published a new report on Basil Extract Market Report to 2031: Forecasts By Form (Powder, Capsule, Oil), By Application (Pharmaceuticals, Personal Care Products, Food & Beverages), By Distribution Channel ((Online Channels, Offline Channels (Organized Retail (Supermarkets & Hypermarkets, Convenience Stores, Departmental Stores, Others), Unorganized Retail)) PLUS Profiles of Leading Basil Extract Manufacturing Companies and Regional and Leading National Market Analysis, PLUS COVID-19 Recovery Scenarios. Increasing demand for natural and
Baking Ingredients Market Report Up to 2031
Baking Ingredients Market Report Up to 2031
Visiongain has published a new report on Baking Ingredients Market Report to 2031: Forecasts by Ingredient Type (Enzymes, Emulsifiers, Leavening Agents, Oils, Fats, and Shortenings, Baking Powder & Mixes, Colors & Flavors, Fiber, Starch, Antimicrobials, Preservatives, Others), By Application (Cakes & Pastries, Bread, Rolls And Pies, Cookies & Biscuits, Others ), By Distribution Channel (B2B, B2C (Online Channels, Offline Channels) PLUS Profiles of Leading Baking Ingredients Manufacturing Companies and Regional
Bakery Enzymes Market Report Up to 2031
Bakery Enzymes Market Report Up to 2031
Visiongain has published a new report on Bakery Enzymes Market Report to 2031: Forecasts by Type (Protease, Lipase, Carbohydrase, Others), By Application (Cakes & Pastries, Bread, Rolls And Pies, Cookies & Biscuits, Others) PLUS Profiles of Leading Baking Enzymes Manufacturing Companies and Regional and Leading National Market Analysis, PLUS COVID-19 Recovery Scenarios. Download Exclusive Sample of Report @ https://www.visiongain.com/report/bakery-enzymes-market/#download_sampe_div COVID-19 Impact on Baking Enzymes Market Baking industry has experienced a significant loss in

All 5 Releases


More Releases for Cancer

Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose. Increase in incidence of target diseases like cancer is key driving factor which is expected to boost
Oncology Nutrition Market led to an unprecedented rise by 2025 : liver cancer, p …
Global Oncology Nutrition Market: Overview Cancer diagnosis creates myriad questions about diet and nutrition. Those pertain to if the food will make a patient feel sick to what should be ingested to fight cancer. This has spawned the oncology nutrition market which has been rising steadily due to the increasing cases of different types of cancer worldwide. During cancer treatment one needs to eat right in order to build up strength
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business. Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports. This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top